These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

931 related articles for article (PubMed ID: 36209270)

  • 41. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ARID1A deficiency is targetable by AKT inhibitors in HER2-negative gastric cancer.
    Sato T; Saito M; Nakajima S; Saito K; Katagata M; Fukai S; Okayama H; Sakamoto W; Saze Z; Momma T; Mimura K; Kono K
    Gastric Cancer; 2023 May; 26(3):379-392. PubMed ID: 36811690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative molecular analysis of colorectal cancer and gastric cancer: What have we learnt?
    Athauda A; Segelov E; Ali Z; Chau I
    Cancer Treat Rev; 2019 Feb; 73():31-40. PubMed ID: 30597479
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives.
    Roviello G; Polom K; Petrioli R; Marano L; Marrelli D; Paganini G; Savelli V; Generali D; De Franco L; Ravelli A; Roviello F
    Tumour Biol; 2016 Jan; 37(1):127-40. PubMed ID: 26566626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incorporating molecular biomarkers into clinical practice for gastric cancer.
    Nakamura S; Kanda M; Kodera Y
    Expert Rev Anticancer Ther; 2019 Sep; 19(9):757-771. PubMed ID: 31437076
    [No Abstract]   [Full Text] [Related]  

  • 48. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
    Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
    Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of miR‑34 in gastric cancer: From bench to bedside (Review).
    Xiong S; Hu M; Li C; Zhou X; Chen H
    Oncol Rep; 2019 Nov; 42(5):1635-1646. PubMed ID: 31432176
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling.
    Liu W; Gou H; Wang X; Li X; Hu X; Su H; Li S; Yu J
    Oncogene; 2021 Dec; 40(49):6666-6679. PubMed ID: 34642500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic and prognostic value of
    Wang MQ; Yin QY; Chen YR; Zhu SL
    Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.
    Patrad E; Khalighfard S; Amiriani T; Khori V; Alizadeh AM
    Cell Oncol (Dordr); 2022 Dec; 45(6):1073-1117. PubMed ID: 36149600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway.
    Huang Y; Zhang J; Hou L; Wang G; Liu H; Zhang R; Chen X; Zhu J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):194. PubMed ID: 29282102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucin 17 inhibits the progression of human gastric cancer by limiting inflammatory responses through a MYH9-p53-RhoA regulatory feedback loop.
    Yang B; Wu A; Hu Y; Tao C; Wang JM; Lu Y; Xing R
    J Exp Clin Cancer Res; 2019 Jul; 38(1):283. PubMed ID: 31262330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressor of cytokine signaling 4 detected as a novel gastric cancer suppressor gene using double combination array analysis.
    Kobayashi D; Nomoto S; Kodera Y; Fujiwara M; Koike M; Nakayama G; Ohashi N; Nakao A
    World J Surg; 2012 Feb; 36(2):362-72. PubMed ID: 22127425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypermethylation in gastric cancer.
    Li Y; Liang J; Hou P
    Clin Chim Acta; 2015 Aug; 448():124-32. PubMed ID: 26148722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 58. Expression and prognostic analyses of HDACs in human gastric cancer based on bioinformatic analysis.
    Chen L; Fei Y; Zhao Y; Chen Q; Chen P; Pan L
    Medicine (Baltimore); 2021 Jul; 100(27):e26554. PubMed ID: 34232196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in the molecular diagnostics of gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LRP4 promotes migration and invasion of gastric cancer under the regulation of microRNA-140-5p.
    Mao Z; Wang Z; Zhang S; Pu Y; Wang J; Zhang T; Long Y; Liu Y; Ma Y; Zhu J
    Cancer Biomark; 2020; 29(2):245-253. PubMed ID: 32675391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.